Contract Research Organization (CRO) Services Market Size, Share and Industry Analysis By Service Type (Discovery, Pre-Clinical, Clinical, Laboratory Services), By Application (Oncology, Cardiology, Infectious Disease, Metabolic Disorders, Others), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, Academic & Research Institutes, Others), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Contract Research Organization (CRO) Services Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Contract Research Organization (CRO) Services market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Contract Research Organization (CRO) Services market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Contract Research Organization (CRO) Services Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Contract Research Organization (CRO) Services Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Contract Research Organization (CRO) Services Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
p2
Key Market Drivers 

  
Pharmaceutical Product Development, LLC.
  
Medpace
  
Clintec
  
IQVIA
  
PRA Health Sciences, Inc.
  
ICON plc
  
KCR S.A.
  
PSI
  
Parexel International Corporation.
  
Covance Inc.
  
Other prominent players

Report Coverage

Pharmaceutical and biotechnology companies outsource various research services to numerous clinical research organizations for hassle-free research management, cost reduction, and ensuring regulatory compliance. Growing investments in the research and development domain by many pharmaceutical companies and the rapidly increasing prevalence of chronic disease are likely to boost the growth of Clinical research organization services market.

Additionally, the rise in several availabilities of clinical trial centers and an increase in the patient pool in the emerging nations are anticipated to drive the growth of global CRO services market during the forecast period.
The report provides qualitative and quantitative insights on the contract research organization services industry trends and detailed analysis of market size and growth rate for all possible segments. It is segmented by type of service, by application, by the end-user, and by region. Based on the service type, the global contract research organizations industry is segmented into discovery, preclinical, clinical, and laboratory services.

Further based on application, the CRO services market segments include oncology, cardiology, infectious disease, metabolic disorders, and others. Various end-users for contract research organizations (CRO) services covered in the report are pharmaceutical & biotechnological companies, medical device companies, academic & research Institutes, and others. Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the world. The regions are further categorized into countries.

Along with this, the report will focus on the elaborative analysis of the contract research organizations market dynamics and competitive landscape. Various key insights provided in the report are mergers & acquisitions among key players operating in the global CRO market, the regulatory scenario in key countries, and the competition matrix for the services provided by many key players.

SEGMENTATION

By Service Type

  
Discovery
  
Pre-Clinical
  
Clinical
  
Laboratory Services

By Application

  
Oncology
  
Cardiology
  
Infectious Disease
  
Metabolic Disorders
  
Others

By End User

  
Pharmaceutical & Biotechnological Companies
  
Medical Device Companies
  
Academic & Research Institutes
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Rest of the World

Key Industry Developments

In February 2019, Pharmaceutical Product Development, LLC. (PPD), signed an agreement with, Happy Lie Tech, a China-based AI Company which focuses on patient recruitment, site selection, and real-world evidence generation

In May 2019, Altasciences went in collaboration with WuXi AppTec to support full scope of drug development programs, from IND-enabling studies to regulatory support for both pre-IND and post-IND stages, as well as document preparation and submission provided by WuXi AppTecs Investigational New Drug (WIND) platform.

In June 2018, Cereno Scientific AB (publ) collaborated with OCT, a full-service clinical CRO operational in Central and Eastern Europe and the U.S. to conduct a phase II study to investigate the antithrombotic effects of Cerenos candidate drug CS1.